Interestingly, ex vivo eosinophil-mediated tumor cell killing via degranulation was recently shown to be partially dependent on CD11b/CD18-mediated adhesion of eosinophils to tumor cells (23), suggesting that physical contact between eosinophils and tumor cells is necessary for eosinophil-mediated killing. This evidence concerns the gene ITGB2 and neoplasm.